Gene · 57697
Papers1,618
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,618
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aplastic Anemia in Triple X Syndrome. | Children (Basel) | 2023 | 36670650 | PubTator, text mining | PubMed |
| The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. | Curr Oncol | 2023 | 36661697 | PubTator, text mining | PubMed |
| The FANCC-FANCE-FANCF complex is evolutionarily conserved and regulates meiotic recombination. | Nucleic Acids Res | 2023 | 36652992 | PubTator, text mining | PubMed |
| Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. | EMBO Mol Med | 2023 | 36652375 | PubTator, text mining | PubMed |
| TMT-based quantitative proteomic analysis reveals the underlying mechanisms of glycidyl methacrylate-induced 16HBE cell malignant transformation. | Toxicology | 2023 | 36641056 | PubTator, text mining | PubMed |
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. | Ann Hematol | 2023 | 36622392 | PubTator, text mining | PubMed |
| MMS22L-TONSL functions in sister chromatid cohesion in a pathway parallel to DSCC1-RFC. | Life Sci Alliance | 2023 | 36622344 | PubTator, text mining | PubMed |
| Characterization and acceleration of genome shuffling and ploidy reduction in synthetic allopolyploids by genome sequencing and editing. | Nucleic Acids Res | 2023 | 36583364 | PubTator, text mining | PubMed |
| The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma. | Cancer Sci | 2023 | 36541483 | PubTator, text mining | PubMed |
| Assessing breast density using the chemical-shift encoding-based proton density fat fraction in 3-T MRI. | Eur Radiol | 2023 | 36538074 | PubTator, text mining | PubMed |
| RMI2 is a novel prognostic and predictive biomarker for breast cancer. | Cancer Med | 2023 | 36533385 | PubTator, text mining | PubMed |
| Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. | Toxicol Sci | 2023 | 36519830 | PubTator, text mining | PubMed |
| Stellettin B Sensitizes Glioblastoma to DNA-Damaging Treatments by Suppressing PI3K-Mediated Homologous Recombination Repair. | Adv Sci (Weinh) | 2023 | 36453577 | PubTator, text mining | PubMed |
| Impact of Asp/Glu-ADP-ribosylation on protein-protein interaction and protein function. | Proteomics | 2023 | 36453556 | PubTator, text mining | PubMed |
| Return of individual genomic research results within the PRAEGNANT multicenter registry study. | Breast Cancer Res Treat | 2023 | 36409394 | PubTator, text mining | PubMed |
| Association of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia. | Cancer Rep (Hoboken) | 2023 | 36382570 | PubTator, text mining | PubMed |
| Leveraging the replication stress response to optimize cancer therapy. | Nat Rev Cancer | 2023 | 36323800 | PubTator, text mining | PubMed |
| Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. | J Natl Cancer Inst | 2023 | 36315097 | PubTator, text mining | PubMed |
| Identification of risk genes in Chinese nonobstructive azoospermia patients based on whole-exome sequencing. | Asian J Androl | 2023 | 36259570 | PubTator, text mining | PubMed |
| Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience. | Prostate | 2023 | 36259290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57697/papers?page=14